New glasses aim to stop myopia in its tracks
NCT ID NCT07645183
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested two types of advanced glasses—lenslet spectacles and violet filter glasses—against standard single-vision lenses to see if they could slow the worsening of nearsightedness (myopia) in 90 people aged 8 to 20. Participants wore the glasses during all waking hours and had their eye measurements taken over 9 months. The goal was to find out if these high-tech lenses can control myopia better than regular glasses.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Lenslet spectacles (Stellest with HALT technology) and violet excitation filter glasses (420 nm wavelength)
- What this could lead to
- If successful, these glasses could offer a non-invasive way to slow myopia progression in children and young adults, reducing the risk of severe nearsightedness later in life.
- What could go wrong
- This is a small, completed trial with 90 participants, so results may not apply to everyone. The effect may be modest, and long-term benefits beyond 9 months are unknown.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYOPIA (DISORDER) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The University of Faisalabad
Faisalābad, Punjab Province, 3800, Pakistan
More trials for these conditions
Other studies related to the condition(s) this trial covers.